Table 1.
LOD Score (θ) for |
|||||
Penetrance |
|||||
Marker | Genetic-MapPositiona(cM) | Affecteds Only | 100% | 75% | 50% |
D7S1842 | 170.3 | .59 (.2) | .20 (.4) | .29 (.3) | .41 (.3) |
D7S2203 | 172.7 | .38 (.2) | .23 (.3) | .39 (.2) | .42 (.2) |
D7S530 | 178.2 | 1.29 (.1) | .89 (.2) | 1.03 (.2) | 1.17 (.1) |
D7S512 | 179.7 | .92 (.1) | .29 (.2) | .68 (.1) | .83 (.1) |
D7S1804b | 180.6 | 3.62 (0) | .98 (.2) | 2.02 (.01) | 3.08 (0) |
D7S631 | 182 | 1.47 (0) | 1.24 (.1) | 1.13 (.05) | 1.19 (.05) |
D7S500 | 184.2 | 4.05 (0) | 1.29 (.2) | 2.19 (.05) | 3.17 (0) |
D7S509 | 186.9 | 4.01 (0) | 2.73 (.1) | 3.11 (.05) | 3.67 (0) |
D7S495 | 188.3 | 1.54 (0) | .57 (.2) | .80 (.1) | 1.05 (.05) |
D7S684 | 190.8 | 1.69 (.05) | .27 (.3) | .67 (.2) | 1.20 (.1) |
D7S2505 | 191.7 | 3.53 (0) | 1.18 (.2) | 1.70 (.1) | 2.57 (0) |
D7S2202 | 193.5 | 3.20 (0) | .77 (.2) | 1.48 (.1) | 2.31 (0) |
D7S1824 | 193.5 | 2.20 (.05) | .49 (.3) | 1.16 (.1) | 1.75 (.05) |
D7S2513 | 194.8 | 3.14 (.05) | 1.03 (.2) | 1.84 (.1) | 2.45 (.05) |
D7S2195 | 200.1 | 2.85 (.05) | 1.39 (.2) | 2.04 (.1) | 2.46 (.05) |
D7S661 | 202.1 | 1.62 (.05) | .15 (.3) | .54 (.2) | 1.05 (.1) |
D7S1798 | 202.7 | .47 (.2) | .05 (.3) | .21 (.2) | .35 (.2) |
D7S2511 | 203.3 | 2.51 (.05) | 1.59 (.2) | 1.94 (.1) | 2.16 (.1) |
D7S688b,c | 206.5 | .54 (.2) | .35 (.2) | .43 (.2) | .49 (.2) |
D7S2426 | 207 | 1.28 (.1) | .27 (.3) | .36 (.3) | .60 (.2) |
D7S505 | 217.5 | .38 (.2) | .09 (.4) | .16 (.3) | .24 (.3) |
Based on the Center for Medical Genetics (Marshfield Medical Research Foundation) gender-averaged genetic map. Marker order was confirmed by reference to a physical map (Bouffard et al. 1997).
Allele frequencies were not available from either CEPH (Fondation Jean Dausset) or the Center for Human Genetics (Duke University Medical Center) and, therefore, are assumed to be equal.
Family 1 only.